Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Liabilities and Shareholders Equity (2016 - 2025)

Dentsply Sirona's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $5.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 5.63% year-over-year to $5.4 billion, compared with a TTM value of $23.2 billion through Dec 2025, down 12.11%, and an annual FY2025 reading of $5.4 billion, down 5.63% over the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $5.4 billion at Dentsply Sirona, down from $5.7 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $9.4 billion in Q2 2021, with the low at $5.4 billion in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $7.5 billion, with a median of $7.4 billion recorded in 2022.
  • Year-over-year, Liabilities and Shareholders Equity increased 13.38% in 2021 and then fell 21.94% in 2024.
  • Tracing XRAY's Liabilities and Shareholders Equity over 5 years: stood at $9.2 billion in 2021, then dropped by 17.27% to $7.6 billion in 2022, then decreased by 3.57% to $7.4 billion in 2023, then fell by 21.94% to $5.8 billion in 2024, then decreased by 5.63% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for XRAY's Liabilities and Shareholders Equity are $5.4 billion (Q4 2025), $5.7 billion (Q3 2025), and $6.1 billion (Q2 2025).